| 产品描述: | 溶于乙醇、乙醚、丙酮,微溶于水。; |
| 体内研究: |
Ethyl pyruvate (80 mg/kg, 腹腔注射, 连续 9 天) 在小鼠肝脏肿瘤模型中可抑制肿瘤生长。 Ethyl pyruvate (2 或40 mg/kg, 腹腔注射) 在百草枯中毒大鼠模型中具有降低脂质过氧化和抗炎作用。 |
| 参考文献: |
1. Fink MP. Ethyl pyruvate: a novel anti-inflammatory agent. J Intern Med. 2007 Apr;261(4):349-62. 2. Olcum M, Tufekci KU, Durur DY, et al. Ethyl Pyruvate Attenuates Microglial NLRP3 Inflammasome Activation via Inhibition of HMGB1/NF-κB/miR-223 Signaling. Antioxidants (Basel). 2021;10(5):745. 3. Liang X, et al. Ethyl pyruvate administration inhibits hepatic tumor growth. J Leukoc Biol. 2009 Sep;86(3):599-607. 4. Qiu X, et al. Ethyl pyruvate confers protection against endotoxemia and sepsis by inhibiting caspase-11-dependent cell pyroptosis. Int Immunopharmacol. 2020 Jan;78:106016. 5. Lee J, et al. Protective effects of ethyl pyruvate treatment on paraquat-intoxicated rats. Hum Exp Toxicol. 2008 Jan;27(1):49-54. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
8.612 ml |
43.059 ml |
86.118 ml |
| 5 mM |
1.722 ml |
8.612 ml |
17.224 ml |
| 10 mM |
0.861 ml |
4.306 ml |
8.612 ml |
| 50 mM |
0.172 ml |
0.861 ml |
1.722 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |